Blood Glucose Monitoring Systems Market Size and Forecasts (2021 - 2031), Global and Regional Share, Trends, and Growth Opportunity Analysis

Coverage: Blood Glucose Monitoring Systems Market covers analysis By Product (Self-Monitoring Blood Glucose Systems, Continuous Glucose Monitoring Systems); Testing Type (Invasive, Non-Invasive); Application (Type 1 Diabetes, Type 2 Diabetes, Gestational Diabetes), and Geography (North America, Europe, Asia Pacific, and South and Central America)

  • Report Code : TIPRE00017781
  • Category : Life Sciences
  • Status : Upcoming
  • No. of Pages : 150
Buy Now

MARKET INTRODUCTION



A blood glucose monitoring system is a medical device used to track and monitor glucose levels in the blood. This system will help the patients to track & monitor the fluctuations in the sugar level. The various components of a blood glucose monitoring system are insulin pumps, sensors, Blood Glucose meters, testing strips, transmitters, and receivers, among others, to monitor it in real-time.

MARKET DYNAMICS



Blood glucose monitoring systems market is driving due to the growing prevalence of diabetes, increasing number of product launches. However, high cost and poor reimbursement of blood glucose monitoring systems and supplies is hindering the market's growth. Moreover, pipeline products and ongoing research and technological advancements in blood glucose monitoring systems is expected to provide opportunities in the global blood glucose monitoring systems market.

MARKET SCOPE



The "Blood Glucose Monitoring Systems Market Analysis to 2031" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of blood glucose monitoring systems market with detailed market segmentation by product, testing type, and application. The blood glucose monitoring systems market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in blood glucose monitoring systems market and offers key trends and opportunities in the market.

MARKET SEGMENTATION



The blood glucose monitoring systems market is segmented on the basis of product, testing type, and application. Based on product, the market is segmented as self-monitoring blood glucose systems, continuous glucose monitoring systems. Based on testing type, the market is segmented as invasive, non-invasive. Based on application, the market is segmented as type 1 diabetes, type 2 diabetes, gestational diabetes.

REGIONAL FRAMEWORK



The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the Blood glucose monitoring systems market based on various segments. It also provides market size and forecast estimates from year 2021 to 2031 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The blood glucose monitoring systems market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting blood glucose monitoring systems market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Blood glucose monitoring systems market in these regions.

MARKET PLAYERS



The report covers key developments in the blood glucose monitoring systems market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Blood glucose monitoring systems market are anticipated to have lucrative growth opportunities in the future with the rising demand for Blood glucose monitoring systems in the global market. Below mentioned is the list of few companies engaged in the Blood glucose monitoring systems market.

The report also includes the profiles of key players in blood glucose monitoring systems market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.

  •   Abbott Laboratories
  •   Medtronic
  •   Ypsomed
  •   F. Hoffmann-La Roche
  •   Lifescan
  •   Ascensia Diabetes Care
  •   Dexcom
  •   B. Braun Melsungen AG
  •   Nipro
  •   Sanofi

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.

Blood Glucose Monitoring Systems Report Scope

Report Attribute Details
Market size in 2023 US$ XX Million
Market Size by 2031 US$ XX Million
Global CAGR (2023 - 2031) XX%
Historical Data 2021-2022
Forecast period 2024-2031
Segments Covered By Product
  • Self-Monitoring Blood Glucose Systems
  • Continuous Glucose Monitoring Systems
By Testing Type
  • Invasive
  • Non-Invasive
By Application
  • Type 1 Diabetes
  • Type 2 Diabetes
  • Gestational Diabetes
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Abbott Laboratories
  • Medtronic
  • Ypsomed
  • F. Hoffmann-La Roche
  • Lifescan
  • Ascensia Diabetes Care
  • Dexcom
  • B. Braun Melsungen AG
  • Nipro
    • Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
    • PEST and SWOT Analysis
    • Market Size Value / Volume - Global, Regional, Country
    • Industry and Competitive Landscape
    • Excel Dataset
    Report Coverage

    Report Coverage

    Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

    Segment Covered

    Segment Covered

    This text is related
    to segments covered.

    Regional Scope

    Regional Scope

    North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

    Country Scope

    Country Scope

    This text is related
    to country scope.

    Trends and growth analysis reports related to Life Sciences : READ MORE..   

    1. Abbott Laboratories
    2. Medtronic
    3. Ypsomed
    4. F. Hoffmann-La Roche
    5. Lifescan
    6. Ascensia Diabetes Care
    7. Dexcom
    8. B. Braun Melsungen AG
    9. Nipro
    10. Sanofi

    Buy Now